BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28821057)

  • 1. A cell-penetrating peptide mediated chitosan nanocarriers for improving intestinal insulin delivery.
    Li L; Yang L; Li M; Zhang L
    Carbohydr Polym; 2017 Oct; 174():182-189. PubMed ID: 28821057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid.
    Chen Z; Han S; Yang X; Xu L; Qi H; Hao G; Cao J; Liang Y; Ma Q; Zhang G; Sun Y
    Int J Nanomedicine; 2020; 15():4877-4898. PubMed ID: 32753869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
    Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Tong Z; Kong X; Yao J
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):278-286. PubMed ID: 27770892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
    Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
    Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
    Guo F; Ouyang T; Peng T; Zhang X; Xie B; Yang X; Liang D; Zhong H
    Biomater Sci; 2019 Mar; 7(4):1493-1506. PubMed ID: 30672923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic Lipopeptide-Mediated Transport of Insulin and Cell Membrane Penetration Mechanism.
    Zhang Y; Li L; Han M; Hu J; Zhang L
    Molecules; 2015 Dec; 20(12):21569-83. PubMed ID: 26633348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ligand conjugated nanoparticles for oral insulin delivery.
    Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y
    Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation.
    Liu L; Zhou C; Xia X; Liu Y
    Int J Nanomedicine; 2016; 11():761-9. PubMed ID: 26966360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
    Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery.
    Wang J; Kong M; Zhou Z; Yan D; Yu X; Cheng X; Feng C; Liu Y; Chen X
    Carbohydr Polym; 2017 Feb; 157():596-602. PubMed ID: 27987967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral insulin delivery by carboxymethyl-β-cyclodextrin-grafted chitosan nanoparticles for improving diabetic treatment.
    Song M; Wang H; Chen K; Zhang S; Yu L; Elshazly EH; Ke L; Gong R
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S774-S782. PubMed ID: 30280608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.
    Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z
    AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
    Urimi D; Agrawal AK; Kushwah V; Jain S
    AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery.
    Zhang YW; Tu LL; Tang Z; Wang Q; Zheng GL; Yin LN
    Pharm Dev Technol; 2021 Nov; 26(9):943-952. PubMed ID: 34372745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
    Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
    Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.